Acute administration of methamphetamine decreases the mRNA expression of diazepam binding inhibitor in rat brain

Tokai Journal of Experimental and Clinical Medicine

Volumn 33, Issue 1, 2008, Pages 51-56

  Tamaki, Raita ^a   Yoshikawa, Masanobu ^a   Shinomiya, Takashi ^b   Hashimoto, Atsushi ^a   Kawaguchi, Mitsuru ^b   Byrne, Daniel W ^c   Kobayashi, Hiroyuki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Anxiety; Diazepam binding inhibitor; Elevated plus maze test; Methamphetamine; Pituitary adenylate cyclase activating polypeptide

Indexed keywords

DIAZEPAM BINDING INHIBITOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; METHAMPHETAMINE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DIENCEPHALON; GENE EXPRESSION; HIPPOCAMPUS; MALE; MAZE TEST; MEDULLA OBLONGATA; MESENCEPHALON; NONHUMAN; NUCLEOTIDE SEQUENCE; PONS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; BRAIN; DIAZEPAM BINDING INHIBITOR; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; METHAMPHETAMINE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 57149083693     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Alho H, Harjuntausta T, Schultz R, Pelto-Huikko M, Bovolin P. Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors. Neuropharmacology 1991; 30: 1381-6.
2. Bovolin P, Schlichting J, Miyata M, Ferrarese C, Guidotti A, Alho H. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul Pept 1990; 29: 267-81.
3. Cho AK, Melega WP, Kuczenski R, Segal DS. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 2001; 39: 161-6.
4. Clemens KJ, Van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology (Berl) 2004; 173: 318-25.
5. Corda MG, Ferrari M, Guidotti A, Konkel D, Costa E. Isolation, purification and partial sequence of a neuropeptide (diazepambinding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition site. Neurosci Lett 1984; 47: 319-24.
6. Davidson C, Lee TH, Ellinwood EH. Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences. Neurochem Int 2005; 46: 189-203.
7. Ferrarese C, Appollonio I, Bianchi G, Frigo M, Marzorati C, Pecora N, Perego M, Pierpaoli C, Frattola L. Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 1993; 18: 3-22.
8. Ferrero P, Costa E, Conti-Tronconi B, Guidotti A. A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain. Brain Res 1986; 399: 136-42.
9. Fukuchi M, Tabuchi A, Tsuda M. Activity-dependent transcriptional activation and mRNA stabilization for cumulative expression of pituitary adenylate cyclase-activating polypeptide mRNA controlled by calcium and cAMP signals in neurons. J Biol Chem 2004; 279: 47856-65.
10. Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A 1983; 80: 3531-5.
11. Katsura M, Ohkuma S, Tsujimura A, Kuriyama K. Increase of diazepam binding inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice. J Pharmacol Exp Ther 1995; 273: 1529-33.
12. Katsura M, Hara A, Higo A, Tarumi C, Hibino Y, Ohkuma S. Continuous treatment with morphine increases diazepam binding inhibitor mRNA in mouse brain. J Neurochem 1998; 71: 2638-41.
13. Katsura M, Ohkuma S, Xu J, Hibino Y, Tsujimura A, Kuriyama K. Continuous treatment with nicotine increases diazepam binding inhibitor (DBI) and its mRNA in the mouse brain. Brain Res Mol Brain Res 1998; 55: 345-9.
14. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987; 92: 180-5.
15. Masmoudi-Kouki O, Gandolfo P, Leprince J, Vaudry D, Pelletier G, Fournier A, Vaudry H, Tonon MC. PACAP stimulates biosynthesis and release of endozepines from rat astrocytes. Ann N Y Acad Sci 2006; 1070: 411-6.
16. Melega WP, Williams AE, Schmitz DA, DiStefano EW, Cho AK. Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 1995; 274: 90-6.
17. Navarro JF, Maldonado E. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 1151-4.
18. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006; 27: 402-9.
19. Payeur R, Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Zealberg J. CSF diazepam-binding inhibitor concentrations in panic disorder. Biol Psychiatry 1992; 32: 712-6.
20. Riviere GJ, Byrnes KA, Gentry WB, Owens SM. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 1999; 291: 1220-6.
21. Russig H, Murphy CA, Feldon J. Behavioural consequences of withdrawal from three different administration schedules of amphetamine. Behav Brain Res 2005; 165: 26-35.
22. Shaw-Lutchman TZ, Impey S, Storm D, Nestler EJ. Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse 2003; 48: 10-7.
23. Shoyab M, Gentry LE, Marquardt H, Todaro GJ. Isolation and characterization of a putative endogenous benzodiazepineoid (endozepine) from bovine and human brain. J Biol Chem 1986; 261: 11968-73.
24. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 2000; 52: 269-324.
25. Yamamoto K, Hashimoto H, Hagihara N, Nishino A, Fujita T, Matsuda T, Baba A. Cloning and characterization of the mouse pituitary adenylate cyclase-activating polypeptide (PACAPgene. Gene 1998; 211: 63-9.
26. Yoshikawa M, Kobayashi T, Oka T, Kawaguchi M, Hashimoto A. Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR. Brain Res Mol Brain Res 2004; 128: 90-4.
27. Tamaki R, Yoshikawa M, Shinomiya T, Andoh H, Kawaguchi M, Hashimoto A, Bryne W D, Kobayashi H. Chronic administration of methamphetamine increases the mRNA expression of diazepam binding inhibitor in rat brain. Tokai J Exp Clin Med 2008; 33: 46-50.